Suwon, South Korea

Eunim Jeong

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ys Life Science Co. Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eunim Jeong. Retrieved from https://idiyas.com/inventor/eunim-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eunim Jeong: Innovator in Pharmaceutical Composition

Introduction

Eunim Jeong is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on lifitegrast. His research focuses on improving the solubility and stability of pharmaceutical compounds.

Latest Patents

Eunim Jeong holds 1 patent for his invention titled "Crystalline form of lifitegrast, and pharmaceutical composition comprising the same." This patent provides a novel crystalline form of lifitegrast, which exhibits improved solubility and excellent stability against heat and moisture. This advancement allows for more effective preparation of pharmaceutical compositions.

Career Highlights

Eunim Jeong is currently employed at Ys Life Science Co. Ltd., where he continues to develop innovative pharmaceutical solutions. His work has garnered attention for its potential impact on drug formulation and delivery.

Collaborations

Eunim collaborates with talented coworkers, including Areum Baek and Hyunik Shin, who contribute to the research and development efforts at Ys Life Science Co. Ltd.

Conclusion

Eunim Jeong's contributions to the pharmaceutical industry through his innovative patent on lifitegrast highlight his role as a key inventor in the field. His work exemplifies the importance of innovation in developing effective pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…